Clinical attributes and surgical outcomes of angiocentric gliomas

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Leonel AmpieOrin Bloch

Abstract

Angiocentric gliomas (AG) are exceedingly rare low-grade neoplasms which often present in the form of intractable epilepsy within younger patients. The current study extensively reviews all reported cases which were pathologically verified as AG in the literature to analyze clinical attributes and surgical outcomes of this neoplasm. There were 88 patients with AG reported in the literature consisting mostly of pediatric cases. The sex distribution consisted of 45 males and 36 females with the remaining seven cases not documenting sex. The average age of initial diagnosis was 16years with almost half of all diagnosed patients being within the first decade of life. In cases where extent of resection was reported, gross total resection (GTR) was achieved in 54 patients, subtotal resection (STR) in 16, and biopsy only in three. Post-operative complications were transient and only occurred in three patients with no reports of death following surgery. Only five cases reported tumor recurrence on follow-up. Eight patients had seizure recurrence post-operatively and GTR offered improved rates of seizure control when compared to STR (p=0.0005). Nearly half of the cases of AG are diagnosed within the first decade of life and they usually...Continue Reading

References

Oct 11, 2005·Journal of Neuropathology and Experimental Neurology·Min WangPeter C Burger
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jan 9, 2008·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Yasuo SugitaHiroshi Baba
Mar 24, 2009·Journal of Child Neurology·Stephen P FultonFrederick A Boop
Apr 3, 2009·Journal of Neurosurgery. Pediatrics·Sophia F ShakurGeorge I Jallo
Jul 1, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Winny VarikattThomas Ng
Jan 30, 2010·Pediatric Neurosurgery·Derek B CovingtonDavid I Sandberg
Mar 10, 2010·Archives of Neurology·Jong Woo LeeEdward B Bromfield
Apr 20, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Xiao-Wu HuPeng-Fei Yang
May 5, 2010·Brain Pathology·Xiaomei MaWeijian Zhu
Aug 4, 2011·Archives of Pathology & Laboratory Medicine·Trent Marburger, Richard Prayson
Sep 3, 2011·Journal of Korean Neurosurgical Society·Gyung-Jun RhoMyoung-Jin Ju
Dec 16, 2011·Brain : a Journal of Neurology·Marjolein de GrootJan J Heimans
Mar 27, 2012·Annals of Diagnostic Pathology·Aditya RaghunathanGregory N Fuller
Feb 5, 2013·Journal of Radiology Case Reports·Hector N AguilarTrevor Kotylak
Apr 19, 2013·The Permanente Journal·Daniela AlexandruMichael G Muhonen
May 28, 2014·Neuropathology and Applied Neurobiology·Hai-Chun NiYue-Shan Piao
Jan 17, 2015·Neurology India·Aanchal KakkarChitra Sarkar
Dec 3, 2015·Journal of Radiology Case Reports·Sainan ChengPearlene Lee

❮ Previous
Next ❯

Citations

Oct 21, 2016·World Neurosurgery·Lain Hermes Gonzalez-QuaranteEmma Sola Vendrell
Sep 22, 2018·Neuro-oncology·Thankamma AjithkumarKieren Allinson
Jan 4, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Shruti GuptaRaj Kumar
Aug 15, 2017·Acta Neuropathologica·Laura D'AroncoBenjamin Ellezam
Mar 5, 2021·Journal of Epilepsy Research·Lanisha D Fuller, Richard A Prayson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.